Contracts › 75N93019F00132
75N93019F00132: Vrc 316/317/320/603 Clinical Monitoring: Pop: 5/1/19 - 3/28/21
Awarded to The Emmes Company, Llc by National Institutes of Health (NIH).
$174Kobligated
$174Kpotential value
31 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93019F00132 |
|---|---|
| Vehicle | HHSN272201700051I |
| Awardee | The Emmes Company, Llc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AZ12 R&D- Other Research and Development (Applied Research/Exploratory Development) |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 30 April 2019 to 31 December 2026 |
| Potential end | 31 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record